Two studies by Ptaszek et al. [52,53] sought to assess the impact of a program of 20 WBC sessions on CAT, GPx, SOD, changes in TAS/TAC, and in the total oxidative status/total oxidative capacity (TOS/TOC) concentration in women with MS, finding no significant changes at the end of the experimental protocol between the study group and the control groups. This evidence concerns the gene CAT and myeloid sarcoma.